American Century Companies Inc Denali Therapeutics Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, American Century Companies Inc holds 451,374 shares of DNLI stock, worth $8.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

451,374

Previous 522,594 13.63%

Holding current value

$8.62 Million

Previous $12.1 Million 8.36%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$20.96 - $31.05 $1.49 Million - $2.21 Million	-71,220 Reduced 13.63%	451,374 $13.1 Million
Q2 2024 Aug 07, 2024	BUY	$14.96 - $23.22 $943,347 - $1.46 Million	63,058 Added 13.72%	522,594 $12.1 Million
Q1 2024 May 14, 2024	SELL	$15.83 - $23.35 $220,955 - $325,919	-13,958 Reduced 2.95%	459,536 $9.43 Million
Q4 2023 Feb 13, 2024	BUY	$16.2 - $23.18 $7.67 Million - $11 Million	473,494 New	473,494 $10.2 Million
Q3 2023 Nov 13, 2023	BUY	$20.63 - $30.17 $8,809 - $12,882	427 Added 0.09%	474,336 $9.79 Million
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $2,944 - $4,152	126 Added 0.03%	473,909 $14 Million
Q1 2023 May 11, 2023	BUY	$21.91 - $32.67 $32,755 - $48,841	1,495 Added 0.32%	473,783 $10.9 Million
Q4 2022 Feb 13, 2023	SELL	$26.28 - $33.92 $2,260 - $2,917	-86 Reduced 0.02%	472,288 $13.1 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $80,325 - $119,173	3,093 Added 0.66%	472,374 $14.5 Million
Q2 2022 Aug 12, 2022	SELL	$20.88 - $35.19 $1.4 Million - $2.36 Million	-67,190 Reduced 12.52%	469,281 $13.8 Million
Q1 2022 May 11, 2022	BUY	$29.0 - $47.27 $5,481 - $8,934	189 Added 0.04%	536,471 $17.3 Million
Q4 2021 Feb 07, 2022	BUY	$42.59 - $55.02 $7.98 Million - $10.3 Million	187,295 Added 53.67%	536,282 $23.9 Million
Q3 2021 Nov 10, 2021	BUY	$48.48 - $78.23 $2.72 Million - $4.39 Million	56,140 Added 19.17%	348,987 $17.6 Million
Q2 2021 Aug 05, 2021	BUY	$50.3 - $78.44 $80,731 - $125,896	1,605 Added 0.55%	292,847 $23 Million
Q1 2021 May 14, 2021	SELL	$53.8 - $81.53 $1.81 Million - $2.74 Million	-33,646 Reduced 10.36%	291,242 $16.6 Million
Q4 2020 Feb 12, 2021	SELL	$36.89 - $93.56 $3.38 Million - $8.57 Million	-91,588 Reduced 21.99%	324,888 $27.2 Million
Q3 2020 Nov 13, 2020	BUY	$23.13 - $38.84 $3,006 - $5,049	130 Added 0.03%	416,476 $14.9 Million
Q2 2020 Aug 13, 2020	BUY	$16.01 - $28.82 $3,602 - $6,484	225 Added 0.05%	416,346 $10.1 Million
Q1 2020 May 14, 2020	SELL	$14.2 - $27.98 $155,149 - $305,709	-10,926 Reduced 2.56%	416,121 $7.29 Million
Q4 2019 Feb 12, 2020	SELL	$14.4 - $19.99 $859,492 - $1.19 Million	-59,687 Reduced 12.26%	427,047 $7.44 Million
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $4.32 Million - $6.57 Million	233,440 Added 92.16%	486,734 $10.1 Million
Q1 2019 May 14, 2019	BUY	$17.99 - $24.65 $4.56 Million - $6.24 Million	253,294 New	253,294 $0

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.56B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Denali Therapeutics Inc. Transaction History